Through the looking glass: current and future perspectives on the role of hormonal interplay in glucose homeostasis.
Kruger
Davida F
DF
The Division of Endocrinology and Metabolism, Henry Ford Health System, Detroit, Michigan (Ms Kruger)
Aronoff
Stephen L
SL
The Research Institute of Dallas, University of Texas Southwestern Medical School at Dallas, and Endocrine Associates of Dallas, Texas (Dr Aronoff)
Edelman
Steven V
SV
Taking Control of Your Diabetes, Del Mar, California, and the Division of Endocrinology, Diabetes and Metabolism, University of California, San Diego, School of Medicine (Dr Edelman)
D000682:Amyloid / Q000502:physiology / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005947:Glucose / Q000378:metabolism*; D006728:Hormones / Q000502:physiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D058228:Islet Amyloid Polypeptide
D000682:Amyloid; D001786:Blood Glucose; D006728:Hormones; D007004:Hypoglycemic Agents; D058228:Islet Amyloid Polypeptide; C105254:pramlintide; D005947:Glucose